Evidence map›Paper›PMID 39841836›Full record

ArticleScience advances2025

Prefrontal 5α-reductase 2 mediates male-specific acute stress response.

Roberto Cadeddu, Giulia Braccagni, Gabriele Floris, Caterina Branca, Eleonora Corridori, Sara Salviati, Pilar Sánchez, Luca Spiro Santovito, Jesus M Torres, Esperanza Ortega and 4 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Acute alcohol triggers rank-specific social ascent through a prefrontal-accumbens circuit in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Roberto CadedduDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-9860-5344
Giulia BraccagniDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-7742-9604
Gabriele FlorisDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-5818-774X
Caterina BrancaDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-6231-2040
Eleonora CorridoriDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.ORCID 0009-0004-9845-885X
Sara SalviatiDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.ORCID 0009-0004-9140-9158
Pilar SánchezDepartment of Biochemistry, Molecular Biology 3 and Immunology, Faculty of Medicine, University of Granada, Granada, Spain.ORCID 0000-0003-4546-5525
Luca Spiro SantovitoThe Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Jesus M TorresDepartment of Biochemistry, Molecular Biology 3 and Immunology, Faculty of Medicine, University of Granada, Granada, Spain.ORCID 0000-0001-9361-6258
Esperanza OrtegaDepartment of Biochemistry, Molecular Biology 3 and Immunology, Faculty of Medicine, University of Granada, Granada, Spain.
Graziano PinnaThe Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0001-7541-4855
Philip J MoosDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-8223-442X
Simona ScheggiDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.ORCID 0000-0002-0229-6090
Marco BortolatoDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-4498-9637

Funding

Alcohol-induced epigenetic reprogramming of PPAR-α affects allopregnanolone biosynthesisR01AA030292 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GRAZIANO PINNA · 2023 to 2026
$1.4M
Mechanisms of information-processing and executive deficits caused by sleep deprivationR56MH130006 · NIMH · UNIVERSITY OF UTAH · PI BORTOLATO, MARCO · 2023 to 2023
$511k
NIAAA NIH HHS R01 AA030292NIMH NIH HHS R56 MH130006
6 · The paper itself

Abstract

A key response to acute stress is the increased brain synthesis of the neurosteroid allopregnanolone (AP). Although the rate-limiting step of this reaction is catalyzed by 5α-reductase (5αR), the role of its two primary isoenzymes, 5αR1 and 5αR2, in stress reactivity remains unclear. Here, we found that acute stress led to increased levels of 5αR2, but not 5αR1, in the medial prefrontal cortex (mPFC) of male, but not female, rats. Down-regulation of 5αR2 in the mPFC significantly reduced stress response in males, and similar sexual dimorphic effects were observed in a novel line of 5αR2 knockout rats. Notably, 5αR1 regulated baseline AP synthesis, whereas 5αR2 enabled AP production under stress. Acute AP administration restored stress response in 5αR2 knockdown rats. Single-nucleus transcriptomics showed that 5αR2 enabled stress-induced protein translation in neurons and glia. These results highlight the crucial role of 5αR2 in mediating sex-specific differences in acute stress reactivity.

Indexed as

3-Oxo-5-alpha-Steroid 4-DehydrogenaseCholestenone 5 alpha-ReductasePrefrontal CortexStress, PhysiologicalStress, PsychologicalAnimalsFemaleMaleNeuronsPregnanoloneRatsRats, Sprague-DawleySex Characteristics3-Oxo-5-alpha-Steroid 4-DehydrogenaseCholestenone 5 alpha-ReductasePregnanolone

Identifiers

PMID39841836
PMCPMC11753402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.